Mirum Pharmaceuticals Patent-Cliff Exposure & CMS Drug Spending Portfolio

Mirum Pharmaceuticals (Foster City, CA): 3 reconciled FDA prescription therapies, $131.2M 2024 CMS Part D & Medicaid spend, and 7 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Headquarters / ClusterFoster City, CA
Reconciled FDA Portfolio Therapies3
2025 to 2030 Patent-Cliff Revenue Exposure0.0%
Primary Portfolio LOE Date2032-01-01
2024 CMS Total Public Spend$131.2M
2024 Medicare Part D Spend$13.8M
2024 Medicaid Spend$117.4M
California HCAI SB 17 Filings7 WAC filings (max 21.7% 2-yr change)